CeMM Research Center for Molecular Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612